| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President &CEO | Chief Operating Officer
1 company
Campbell Bradley L is a President And CEO at AMICUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $14.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 20,002 | $12.70 | $254,019.81 | -2.8% | |
| May 26, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 2,500 | $13.01 | $32,525.00 | -0.7% | |
| May 1, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 17,503 | $11.33 | $198,238.98 | -4.7% | |
| Apr 7, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 2,500 | $10.12 | $25,300.00 | -0.7% | |
| Apr 1, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 15,003 | $9.09 | $136,309.76 | -4.1% | |
| Mar 5, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 2,500 | $10.01 | $25,025.00 | -0.7% | |
| Mar 2, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 15,003 | $9.09 | $136,444.78 | -4.0% | |
| Feb 5, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 2,500 | $10.01 | $25,025.00 | -0.7% | |
| Feb 3, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 15,003 | $8.91 | $133,625.72 | -4.0% | |
| Jan 15, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sell | 5,064 | $10.35 | $52,388.09 | -1.3% |